Canada Markets open in 4 hrs 11 mins

MariMed Inc. (MRMD.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.60000.0000 (0.00%)
At close: 12:05PM EDT
Full screen
Previous Close0.6000
Bid0.3100 x N/A
Ask7.9700 x N/A
Day's Range0.0000 - 0.0000
52 Week Range
Avg. Volume4,773
Market Cap210.803M
Beta (5Y Monthly)3.06
PE Ratio (TTM)N/A
Earnings DateMay 08, 2023 - May 12, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    MariMed Announces Close on Acquisition of Ermont, Inc. Operating Assets

    NORWOOD, Mass., March 13, 2023 (GLOBE NEWSWIRE) -- MariMed, Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator, and Ermont Inc. (“Ermont”) a vertically integrated medical cannabis operator located in Quincy, MA, today announced the close of MariMed’s transaction to acquire the operating assets of Ermont. The deal was previously announced on February 21, 2023. The acquisition marks the second medical dispensary for MariMed in Massachusetts, substa

  • GlobeNewswire

    MariMed Reports Fourth Quarter and Full Year 2022 Financial Results

    NORWOOD, Mass., March 01, 2023 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the fourth quarter and full year ended December 31, 2022. “I am pleased to report that our fourth quarter revenue grew sequentially and year-over-year as we continued to outperform the industry in all of our key states,” said Jon Levine, Chief Executive Office

  • GlobeNewswire

    MariMed Board of Directors Appoints Edward Gildea as Chairman and Jon Levine as Chief Executive Officer

    NORWOOD, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- MariMed, Inc. (CSE: MRMD), (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator (“MSO”), today announced its Board of Directors (the “Board”) has appointed Edward Gildea as Chairman of the Board and Jon Levine as Chief Executive Officer. Mr. Gildea has served as an independent director of the Company since 2013. Mr. Levine, co-founder and President of MariMed, has served as Interim CEO since the December passing of